Children's Place Q3 adjusted EPS $3.33 vs $5.43 YoY; lowers FY22 guidance to $4.05-$4.30

Childrens Place, Inc.

2022-Q3 EPS reported $3.68 revenue$1,252,355,000

Net sales $509.1M, down 8.8% YoY; comp sales down 10%.
GAAP EPS $3.26, adjusted $3.33; both down sharply from $5.30/$5.43 in Q3 2021.
Gross margin 34.8%, deleveraged 910 bps on higher supply chain costs.
FY22 adjusted EPS guidance lowered to $4.05-$4.30; Q4 guidance $0.50-$0.75.
Inventories up 24% to $549M; repurchased 434k shares for $18M in Q3.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Childrens Place, Inc. reported Fiscal 2022 results: EPS $4.05 to $4.30. Guidance lowered.

Period: Fiscal 2022
EPS: $4.05 to $4.30
Guidance: lowered
Result: guidance update

Exact text from the filing

Updates Full Year 2022 Adjusted EPS Guidance to $4.05 to $4.30

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Childrens Place, Inc. reported third quarter ended October 29, 2022 results: revenue $509.1 million, EPS $3.26. Guidance lowered.

Period: third quarter ended October 29, 2022
Revenue: $509.1 million
EPS: $3.26
Guidance: lowered
Result: reported results

Exact text from the filing

structural changes made to the Company’s operating model since the onset of the COVID-19 pandemic. Third Quarter 2022 Results Net sales decreased $49.1 million, or 8.8%, to $509.1 million in the three months ended October 29, 2022, compared to $558.2 million in the three months ended October 30, 2021, and decreased $15.7 million, or 3.0%, compared to $524.8

View on SEC.gov

Browse all earnings releases →

Childrens Place, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-119722

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.